Novartis Pharmaceuticals Corporation v. Lupin Inc. et al
Plaintiff: Novartis Pharmaceuticals Corporation
Defendant: Lupin Pharmaceuticals, Inc., Lupin Atlantis Holdings, S.A., Lupin Limited and Lupin Inc.
Case Number: 1:2024cv01045
Filed: September 18, 2024
Court: U.S. District Court for the District of Delaware
Presiding Judge: Richard G Andrews
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. ยง 271 Patent Infringement
Jury Demanded By: None
Docket Report

This docket was last retrieved on October 2, 2024. A more recent docket listing may be available from PACER.

Date Filed Document Text
October 2, 2024 Filing 9 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Lupin Pharmaceuticals, Inc. waiver sent on 9/25/2024, answer due 11/25/2024. (Silver, Daniel)
October 2, 2024 Filing 8 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Lupin Limited waiver sent on 9/25/2024, answer due 11/25/2024. (Silver, Daniel)
October 2, 2024 Filing 7 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Lupin Inc. waiver sent on 9/25/2024, answer due 11/25/2024. (Silver, Daniel)
October 2, 2024 Filing 6 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Lupin Atlantis Holdings, S.A. waiver sent on 9/25/2024, answer due 11/25/2024. (Silver, Daniel)
September 25, 2024 Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
September 25, 2024 Remark: The MDL panel has been advised. (mpb)
September 18, 2024 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (mpb)
September 18, 2024 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,101,659; 11,096,918. (mpb)
September 18, 2024 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/6/2024. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 2/6/2027. (mpb)
September 18, 2024 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb)
September 18, 2024 Filing 1 COMPLAINT against Lupin Atlantis Holdings, S.A., Lupin Inc., Lupin Limited, and Lupin Pharmaceuticals, Inc. (Filing fee $ 405, receipt number ADEDC-4501085) - filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibits A-B, #2 Civil Cover Sheet)(mpb) Modified on 9/25/2024 (nms).
September 18, 2024 No Summons Issued. (mpb)

Access additional case information on PACER

Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Novartis Pharmaceuticals Corporation v. Lupin Inc. et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Lupin Pharmaceuticals, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Lupin Atlantis Holdings, S.A.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Lupin Limited
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Lupin Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Novartis Pharmaceuticals Corporation
Represented By: Alexandra M. Joyce
Represented By: Daniel M. Silver
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?